Nurse-led drug monitoring in the rheumatology clinic
Clinical Previous     Next

Nurse-led drug monitoring in the rheumatology clinic

Sarah Ryan Clinical Nurse Specialist in Rheumatology, At the Haywood Hospital, Burslem, Stoke-on-Trent

For rheumatology nurses, role extension means taking responsibility for monitoring the drugs used in the treatment of inflammatory arthritis. This article describes how nurse- led monitoring works in one clinic, and how it may offer a more holistic type of care

Nurses are increasingly incorporating into their skills areas of care traditionally undertaken by medical colleagues. In rheumatology, nurses have taken responsibility for monitoring disease-modifying antirheumatic drugs (DMARDs) and cytotoxic therapy. Phelan et al (1992) found that 86 per cent of rheumatology nurse specialists considered drug monitoring to be part of their role

Nursing Standard. 11, 24, 45-47. doi: 10.7748/ns.11.24.45.s52

You need a subscription to read the full article